Big Move For Aurinia Pharmaceuticals Inc.

Tue, May 10, 2022 at 05:30 PM
Big Move For Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ) soared at $11.27, representing a gain of 26%. On Mon, May 09, 2022, AUPH:NASDAQ hit a New 2-Week Low of $8.95. The stock got featured on our News Catalysts scanner on Tue, May 10, 2022 at 06:32 AM in the 'EARNINGS' category. From Mon, Apr 25, 2022, the stock recorded 30.00% Up Days and 36.36% Green Days

About Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ)

Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The Company is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.